An Introduction to Anterior Segment
There have been significant treatment updates for diseases and conditions that affect the components of the anterior segment. Examples include recent advances in cataract surgery, including the introduction of femtosecond laser-assisted cataract surgery and new intraocular lens (IOL) technology, and procedures such as Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet membrane endothelial keratoplasty (DMEK), which have significantly advanced corneal surgery.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Anterior Segment Content
Optimizing IOL selection: Focus on IOL calculations in “difficult” eyes
Watch experts in ophthalmology discuss preoperative evaluations and IOL calculations to optimize postoperative refractive outcomes in cataract patients.
- Describe the preoperative assessment of ocular health in patients scheduled for cataract surgery
- Discuss biometry and IOL calculations to achieve optimum postoperative refractive outcomes in cataract patients
- Recognize how previous refractive surgeries and corneal pathologies in cataract patients impact biometry, IOL calculations and lens selection
John D Sheppard, Hawaiian Eye and Retina 2023: Phaco and keratopathy – sequential or combined keratoplasty?
It was a pleasure to have the opportunity to meet with Dr John D Sheppard (Eastern Virginia Medical School, Norfolk, VA, USA) about his presentation on what to consider when choosing between sequential or combined keratoplasty. Questions: What are the advantages and disadvantages of combined phacoemulsification and keratoplasty versus sequential surgery? (0:10) What patient factors […]
John D Sheppard, Hawaiian Eye and Retina 2023: Highlights
We were delighted to speak with Dr John D Sheppard (Eastern Virginia Medical School, Norfolk, VA, USA) about his highlights from Hawaiian Eye and Retina 2023, and his views on the role of penetrating keratoplasty in the era of selective lamellar keratoplasty. Questions: What have you gained most from attending the Hawaiian Eye meeting? (0:09) […]
Pilocarpine Hydrochloride Ophthalmic Solution 1.25%: An Innovative Prescription Eye Drop for the Treatment of Presbyopia
touchREVIEWS in Ophthalmology. 2022;16(2):54–62 DOI: https://doi.org/10.17925/USOR.2022.16.2.54
Presbyopia is a progressive, age-related condition that reduces the eye’s ability to focus on near objects, due to gradual lens thickening and decline in its elasticity and accommodative capacity, and represents the first stage of the dysfunctional lens syndrome.1–3 Presbyopia typically affects individuals aged >40 years and is highly prevalent, affecting nearly 2 billion people worldwide […]
Chhavi Saini, ASCRS 2022: Clinical outcomes of Boston keratoprosthesis type 2
The Boston Keratoprosthesis type II (BK2) device may be the only viable option to salvage vision in patients with severe cicatrizing ocular surface disease. The prior BK2 model was modified to the present day (click-on) model in 2009. The clinical outcomes of the current click-on BK2 model is discussed in this touchOPHTHALMOLOGY interview with Dr […]
Eduardo Roditi, ASCRS 22: Topical timolol 0.25% to enhance preoperative reference vessels image in digitally assisted intraoperative axis alignment for toric IOL
When capturing a scleral image in the biometry occasionally an error message can appear as “not enough vessels near the limbus have been found”, in consequence, using the intraoperative toric axis assistant is not possible. Timolol 0.25% is a common and available non-selective beta-adrenergic blocker. The use of topical timolol 0.25% drops as an effective […]
Christopher Lievens, ARVO 2022: GEMINI 1 and GEMINI 2 pooled phase 3 studies: extended depth of focus from AGN-190584
The clinical outcomes of the GEMINI 1 and GEMINI 2 studies are discussed in this touchOPHTHALMOLOGY interview with Prof. Christopher Lievens (Southern College of Optometry, Memphis, Tennessee, USA). If approved, AGN-190584 is expected to be the first eye drop for the treatment of presbyopia, the eye’s reduced ability to focus on near objects. The presentation […]
William F Mieler, Hawaiian Eye 2022: Management of Endophthalmitis following Anterior Segment Surgery
Posterior segment complications are an ever-present challenge post-surgery, according to a presentation at Hawaiian Eye 2022. It was great to catch up with Dr William F Mieler (University of Illinois Chicago, IL, USA), who talked through the best approaches for the management of endophthalmitis following anterior segment surgery. The abstract entitled Posterior Segment Complications of […]
William F Mieler, Hawaiian Eye 2022: Posterior Segment Complications of Anterior Segment Surgery
Posterior segment complications are an ever-present challenge post-surgery, according to a presentation at Hawaiian Eye 2022. We had the pleasure of speaking with Dr William F Mieler (University of Illinois Chicago, IL, USA) about complications following anterior segment surgery. The abstract entitled Posterior Segment Complications of Anterior Segment Surgery was presented at Hawaiian Eye 2022, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!